Leukemia | Tumor

CURE’s leukemia page is a go-to resource for oncology news and updates in the world of leukemia Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in leukemia.

Caring Deeply About Patients With Cancer, Colleagues and Clinical Research

May 6th 2022

Ilene Galinsky, ANP-BC, "had the courage to fiercely stand up for her patients’ best interests despite conventions of rank, seniority and arbitrary rules," a colleague said.

Patient With Leukemia Subtype Undergoes Stem Cell Transplant After Receiving Novel Monotherapy in Early-Phase Trial

April 1st 2022

Treatment with a novel monotherapy in a patient with relapsed/refractory acute myeloid leukemia was effective enough that a successful, as indicated by a significant reduction in bone marrow blasts, stem cell transplant was performed.

Uncharted Territory: How a Cancer Nurse Navigated Her Child’s Leukemia Diagnosis

February 3rd 2022

On this episode of the “Cancer Horizons” podcast, a cancer nurse explains how her son’s leukemia diagnosis transformed her work, her research and her outlook on life.

Wearable Remote Monitoring Device May Help Patients With Blood Cancers Identify When to Seek Follow-Up Care

January 20th 2022

Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.

Expert Explores the Relationship Between Down Syndrome and Leukemia

January 6th 2022

In this episode of the “Cancer Horizons” podcast, an expert unpacks cancer risks for individuals with Down syndrome and analyzes the results of a recent study about mortality risks for childhood survivors later in life.

Mortality Risk Later in Life May Be Increased in Childhood Leukemia Survivors With Down Syndrome

January 3rd 2022

Patients with Down syndrome have an increased risk for leukemia during childhood, and toxicities related to treatment may be more common in this patient population.

Procter & Gamble Issues Product Recall Due to Cancer-Causing Chemical, Cancer Survivor Pays for Another Family’s Christmas and More

December 24th 2021

From a Procter & Gamble shampoo and conditioner recall due to the presence of benzene, a cancer-causing chemical, to heartwarming acts of holiday kindness for cancer survivors and their families, here’s what’s happening in the cancer landscape this week.

Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers

December 23rd 2021

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

FDA Approves Orencia for GVHD Prevention After Hematopoietic Stem Cell Transplant

December 15th 2021

The Food and Drug Administration approved Orencia, which is commonly used to treat conditions like rheumatoid arthritis, to prevent acute graft-versus-host-disease in adults and children who underwent a hematopoietic stem cell transplant from an unrelated donor.

Kymriah May Be Safe and Effective in Children and Young Adults With Acute Lymphoblastic Leukemia Subtype

December 12th 2021

The immunotherapy Kymriah offered similar benefits in patients younger than and older than 18 years with relapsed/refractory B-cell acute lymphoblastic leukemia.

Cancer Clinical Trial Enrollment Is Low in the US, and Patient Depression and Anxiety May Play a Role

December 12th 2021

Researchers found that depression and anxiety may skew patient perceptions of participating in blood cancer clinical trials, thus contributing to low enrollment throughout the United States.

FDA Approves Rituxan-Chemotherapy Combo for Children with a Variety of Blood Cancers

December 3rd 2021

The FDA approval of Rituxan plus chemotherapy is indicated for the treatment of children aged six months to 18 years who have various forms of lymphoma or a form of leukemia.

Assessing Both Sides of the Argument for In-Home Cancer Infusions

November 18th 2021

Although the interest of at-home care including the administration of cancer infusions has grown since the start of the COVID-19 pandemic, hesitation looms over its convenience, cost and safety.

FDA Approves Scemblix for Pretreated CML in the Chronic Phase

October 29th 2021

The Food and Drug Administration approved Scemblix for patients with Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase whose disease progressed on prior TKI treatment.

New Treatments and Tips for Dealing With Blood Cancer

October 26th 2021

New research in blood cancer includes new treatment options for acute myeloid leukemia and a novel therapy using BK virus-specific T cells to treat BK virus-associated hemorrhagic cystitis.

The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect

October 21st 2021

A new T-cell therapy can be highly effective in treating BKV-associated hemorrhagic cystitis while minimizing side effects.

What Patients With Blood Cancers Need to Know About COVID-19, Booster Shots and More

October 21st 2021

An expert from the Leukemia & Lymphoma Society breaks down the effectiveness of the COVID-19 vaccine in patients with blood cancers on this episode of the “Cancer Horizons” podcast.

Bouncing Back: The Leukemia Survivor Who Became a Bone Marrow Transplant Nurse

October 21st 2021

A three-time acute lymphoblastic leukemia survivor became a bone marrow transplant nurse and now helps other patients with the same diagnosis.

Gleevec: A 'Miracle Drug' for Some Patients With Chronic Myeloid Leukemia

October 18th 2021

Gleevec was approved by the FDA in 2001. The groundbreaking oral drug has since been a lifesaver for many patients with chronic myeloid leukemia.

Third COVID-19 Vaccine Dose in Blood Cancers May Boost Antibody Production

October 13th 2021

Patients with blood cancers may respond differently to doses of the COVID-19 vaccines based on the treatment they’re receiving, for example.

FDA's Tecartus Approval Offers 'More Specific Answer' to Patients with Relapsed Acute Lymphoblastic Leukemia

October 11th 2021

An expert and a patient discuss their experiences with Tecartus, the newly approved CAR-T cell therapy for certain patients with acute lymphoblastic leukemia.

A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy

October 11th 2021

Natural killer cell therapy is making strides in blood cancer research, but there’s still much more to learn.

How Surviving Cancer Made One Oncologist More Empathetic to His Patients

October 8th 2021

After undergoing treatment for leukemia in the middle of his career as a radiation oncologist, Dr. Curtis Mack noticed that he became a more empathetic and patient doctor.

An Oncologist Who Understands Surviving the Other Side of Cancer

October 7th 2021

Dr. Curtis Mack can relate to his patients on a level other radiation oncologists might not be able to because he has received a diagnosis, gone through treatment and survived cancer himself.

Understanding the Variability of a Rare Blood Cancer

October 5th 2021

An expert discusses two primary unmet needs in myelofibrosis, current treatments and new approaches to this complex disease.

FDA Approves Tecartus for Relapsed/Refractory Acute Lymphoblastic Leukemia

October 1st 2021

The FDA approved Tecartus, a CAR-T cell therapy, for the treatment of patients with relapsed/refractory acute lymphoblastic leukemia.

FDA Approval of Jakafi for Chronic GVHD Provides Another Option, But ‘More Work Needs to Be Done’

September 29th 2021

While the recent FDA approval of Jakafi offers another effective option for patients with chronic GVHD, one expert urges that more work needs to be done to prevent and/or reverse the condition.

FDA Approves Jakafi for Chronic GVHD

September 22nd 2021

The FDA has granted approval to Jakafi (ruxolitinib) for the treatment of chronic graft-versus-host disease (GVHD).

Chronic GVHD Treatment Improves, But Is Still Far From Perfect

September 20th 2021

Patients with blood cancer who underwent stem cell transplant and developed chronic graft-versus-host disease have more treatment options than ever before. But the formula for planning older and newer therapies has not yet been established.

Patients With Blood Cancers and COVID-19 May Benefit From Convalescent Plasma Therapy

September 2nd 2021

The use of convalescent plasma therapy in patients with blood cancers and COVID-19 was associated with an improvement in survival from the infection.

NEXT PAGE
PREVIOUS PAGE